Latest Cholangiocarcinoma Stories
Pancreatic cancer is one of the most challenging tumors to treat.
Intrahepatic cholangiocarcinoma (ICC) is a cancer of the bile duct in the liver.
Researchers have identified a set of "molecular signatures" for biliary atresia â€“ the most common diagnosis leading to liver transplant in children â€“ that can help identify the progression of disease at diagnosis and predict clinical outcomes.
Researchers identify an enzyme important for cancerâ€™s ability to spread.
CHICAGO, June 6 /PRNewswire/ -- NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcuteÂ®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer.
Patients who have gastric cancer surgery followed by chemotherapy have an associated decreased risk of death and improved disease-free survival compared to patients who have surgery alone.
NATICK, Mass., April 30 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that multiple clinical abstracts examining the diagnostic and therapeutic utility of its SpyGlass(Â®) Direct Visualization System, Radial Jaw(Â®) 4 Biopsy Forceps and WallFlex(Â®) Duodenal Stent will be presented at Digestive Disease Week(Â®) (DDW(Â®)), May 1 - 5 in New Orleans.
Risk of non-Hodgkin lymphoma and cholangiocarcinoma in Taiwanese parous women with chronic hepatitis B virus infection.
Even though older patients with colon cancer are less likely to receive chemotherapy following surgery because of concerns of adverse events, new research indicates that when they do receive this treatment, it is less toxic and of shorter duration than therapy younger patients receive, and older patients experience fewer adverse events.
SAN DIEGO, Calif., March 4 /PRNewswire/ -- bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE IDÂ®, and the launch of KRAS mutational testing.
The Chinese liver fluke (Clonorchis sinensis) is a species of parasitic worm that is classified within the Platyhelminthes phylum. It can be found in Southeast Asia, Taiwan, Japan, and China and is present in nearly 30,000,000 humans today. It is thought to be one of the world’s most pervading parasites. The Chinese liver fluke requires two intermediate, or secondary, hosts and one definitive, or main, host to successfully complete its lifecycle. The first intermediate host is typically...
- A person in a secondary role, specifically the second most important character (after the protagonist).